Understanding the biology of low-risk prostate cancer
Official title: Defining the Biological Arc of Grade Group 1 Prostate Cancer
Funded at University of Michigan at Ann Arbor · NIH-10897021 · Data updated 2026-11-12
This study is looking at Grade Group 1 prostate cancer to see how it behaves over time and whether it has any similarities to more aggressive types, especially in African American men, so we can better understand what might indicate a need for more treatment.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | August 1, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $339,008 |
| NIH project number | 5R37CA283857-02 |
| Project ID | NIH-10897021 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include men diagnosed with Grade Group 1 prostate cancer, particularly those who are African American.
✕Less likely to help
Patients with higher-grade prostate cancer or those not diagnosed with prostate cancer may not benefit from this research.
What this research studies
This research aims to clarify the biological behavior of Grade Group 1 prostate cancer, which is often monitored rather than treated immediately. The study will investigate whether this type of cancer progresses over time and if it shares molecular characteristics with more aggressive forms of prostate cancer. By analyzing tissue samples and molecular features, the research seeks to identify any indicators that could predict the presence of higher-grade cancer in patients. This work is particularly focused on understanding how these factors may differ in African American men.
Why it matters
Potential benefit: If successful, this research could lead to more accurate monitoring strategies for patients with low-risk prostate cancer, potentially reducing unnecessary treatments.
How similar studies have gone: Previous research has shown promise in understanding the biological behavior of prostate cancer, but this specific focus on Grade Group 1 and its implications for African American men is relatively novel.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Salami, Simpa Samuel — University of Michigan at Ann Arbor
- Study coordinator: Salami, Simpa Samuel
Related research
Other NIH-funded projects on the same topics.
-
Cardiovascular risk planning and reduction for men with prostate cancer
A program to better predict and reduce heart disease risk in men treated for prostate cancer, especially older patients.
-
Effects of ADT on motivation and emotion in prostate cancer patients
This project looks at how androgen deprivation therapy may affect motivation and mood over time in men with prostate cancer.
-
Causal Protein Markers to Understand and Predict Prostate Cancer Risk in Africans and Europeans
A cancer research project looking at proteins linked to prostate cancer to better understand why it happens and how risk differs between African and European populations.
-
Ethical multimodal AI platform to improve prostate cancer detection with ultrasound
A patient-friendly AI system uses ultrasound and MRI information to help doctors better find prostate cancer, aiming to improve accuracy and access.
-
Characterizing epigenetic targets in prostate cancer to help AR-driven cancer
A research project at MD Anderson aims to understand how epigenetic factors shape androgen receptor signaling in prostate cancer to find new ways to treat resistant forms of the disease.
-
AR and RNA-binding in prostate cancer resistance
A cancer research grant exploring how the androgen receptor’s interaction with RNA may drive treatment resistance in prostate cancer, with potential to guide new therapies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.